Publications by authors named "Daniel A Davis"

Claim this Profile
C
Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug.
Miguel O Jara, Beatriz Behrend-Keim, Giselle Bedogni, Lina Vargas Michelena, Daniel A Davis

Int J Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blunt Ocular Trauma in Sport.
Arthur Davis Daniel, Suraj Achar, Mihir Parikh

Curr Sports Med Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison.
Stephen A Thompson, Urvi Gala, Daniel A Davis, Sandra Kucera, Dave Miller

AAPS PharmSciTech· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution.
Stephen A Thompson, Daniel A Davis, Dave A Miller, Sandra U Kucera, Robert O Williams

Biomedicines· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Drug Loading of Weakly Acidic Telmisartan in Amorphous Solid Dispersions through pH Modification during Hot-Melt Extrusion.
Stephen A Thompson, Daniel A Davis, Chaeho Moon, Robert O Williams

Mol Pharm· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curettage of skin cancer-the bruised apple analogy.
Kevin Shi, Derek Davis, Daniel A Davis, Divya Srivastava, Rajiv I Nijhawan

Dermatol Online J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity.
Daniel A Davis, Dave A Miller, Supawan Santitewagun, J Axel Zeitler, Yongchao Su

Int J Pharm X· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Laser Sintering of a Photosensitive Drug: Impact of Processing and Formulation Parameters on Degradation, Solid State, and Quality of 3D-Printed Dosage Forms.
Rishi Thakkar, Daniel A Davis, Robert O Williams, Mohammed Maniruzzaman

Mol Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formulations and drug delivery systems to administer biological solids.
Yajie Zhang, Daniel A Davis, Khaled AboulFotouh, Jieliang Wang, Donna Williams

Adv Drug Deliv Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Laser Sintering 3-Dimensional Printing as a Single Step Process to Prepare Amorphous Solid Dispersion Dosage Forms for Improved Solubility and Dissolution Rate.
Daniel A Davis, Rishi Thakkar, Yongchao Su, Robert O Williams, Mohammed Maniruzzaman

J Pharm Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
Deck Khong Tan, Daniel A Davis, Dave A Miller, Robert O Williams, Ali Nokhodchi

AAPS PharmSciTech· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities.
Daniel A Davis, Dave A Miller, Yongchao Su, Robert O Williams

AAPS PharmSciTech· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients.
Daniel A Davis, Patricia P Martins, Michael S Zamloot, Shawn A Kucera, Robert O Williams

AAPS PharmSciTech· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.
Hiroyuki Takabe, Zachary N Warnken, Yajie Zhang, Daniel A Davis, Hugh D C Smyth

Pharmaceutics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
Zachary N Warnken, Hugh D C Smyth, Daniel A Davis, Steve Weitman, John G Kuhn

Mol Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.
Zhenyu Lin, Amelia McDermott, Lijian Shao, Aarthi Kannan, Michael Morgan, Daniel A Davis

Cancer Lett· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All monofilament knots assume sliding conformation in vivo.
Daniel A Davis, Donna M Pellowski, Eric J Rawdon

Dermatol Surg· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimize oxidation for the fastest hematoxylin staining.
Daniel A Davis

Dermatol Surg· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational study to validate the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy) questionnaire.
Richard R Rubin, Mark Peyrot, Catherine P Metzinger, Yaping Xu, Barbara Lippe, Daniel Aaron Davis

Curr Med Res Opin· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
Mary Jayne Kennedy, Daniel A Davis, Ned Smith, Andrea Gaedigk, Robin E Pearce

Clin Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination forceps fuse both safety and efficiency.
Lance B Henry, Donna M Pellowski, Daniel A Davis

Dermatol Surg· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnostic concordance of actinic keratosis and squamous cell carcinoma.
Daniel A Davis, John P Donahue, James E Bost, Thomas D Horn

J Cutan Pathol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of pseudoxanthoma elasticum?
Misty T Sharp, Daniel A Davis

Dermatol Surg· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrarapid staining for cutaneous melanoma: study and protocol.
Daniel A Davis, Kevin A Kurtz, Robert A Robinson

Dermatol Surg· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of frozen sections.
Daniel A Davis, Donna M Pellowski, C William Hanke

Dermatol Surg· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis